Brief ReportBrief Communication
Open Access
Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia
Orhan Ayyildiz, Abdurrahman Isikdogan, Zahit Bolaman and Ekrem Muftuoglu
Saudi Medical Journal December 2004, 25 (12) 2054-2056;
Orhan Ayyildiz
Department of Hematology-Oncology, Dicle University, Faculty of Medicine, 21100, Diyarbakir, Turkey. E-mail: [email protected]
Abdurrahman Isikdogan
Department of Hematology-Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
Zahit Bolaman
Department of Hematology-Oncology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
Ekrem Muftuoglu
Department of Hematology-Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
![Loading Loading](https://smj.org.sa/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
![PDF extract preview](https://smj.org.sa/content/25/12/2054.extract.jpg)
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Saudi Medical Journal
Vol. 25, Issue 12
1 Dec 2004
Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia
Orhan Ayyildiz, Abdurrahman Isikdogan, Zahit Bolaman, Ekrem Muftuoglu
Saudi Medical Journal Dec 2004, 25 (12) 2054-2056;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.